Literature DB >> 11160238

IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis.

A C La Flamme1, E A Patton, B Bauman, E J Pearce.   

Abstract

Liver enlargement and hepatocyte proliferation, normal responses in wild-type (WT) mice infected with the parasitic helminth Schistosoma mansoni, were found to be severely impaired in infected IL-4(-/-) mice. Compared with WT mice, increased levels of O(2)(-), NO, and the more highly reactive ONOO(-) were detected in the liver and produced by lesional cells isolated from liver granulomas of infected IL-4(-/-) mice. Concurrently, antioxidant defenses in the liver, specifically catalase levels, diminished dramatically during the course of infection in these animals. This contrasted to the situation in infected WT mice, where catalase levels remained as high as those in normal mice. Actual levels of reactive oxygen and nitrogen intermediates in the livers of infected IL-4(-/-) animals are thus likely to be considerably higher than those in the livers of infected WT mice. To determine whether these changes contributed to the development of the more severe disease that characterizes infection in the IL-4(-/-) animals, we treated infected IL-4(-/-) mice with uric acid, a potent scavenger of ONOO(-). This resulted in significantly increased hepatocyte proliferation, decreased morbidity, and prolonged survival. Taken together, these data indicate that IL-4 is playing a protective role during schistosomiasis by controlling the tight regulation of the generation of reactive oxygen and nitrogen intermediates in the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160238     DOI: 10.4049/jimmunol.166.3.1903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Immunology of parasitic helminth infections.

Authors:  Andrew S MacDonald; Maria Ilma Araujo; Edward J Pearce
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  Macrophage activation governs schistosomiasis-induced inflammation and fibrosis.

Authors:  Luke Barron; Thomas A Wynn
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

3.  Differential liver protein expression during schistosomiasis.

Authors:  Marina Harvie; Thomas William Jordan; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  IFN-γ-driven IDO production from macrophages protects IL-4Rα-deficient mice against lethality during Schistosoma mansoni infection.

Authors:  Reena Rani; Michael B Jordan; Senad Divanovic; De'Broski R Herbert
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

5.  IL-4 and IFN-γ induced by human immunodeficiency virus vaccine in a schistosome infection model.

Authors:  Jiangmei Yin; Anlan Dai; Tatiana Arango; Ravi S Kasinathan; Robert M Greenberg; Jean D Boyer
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

6.  Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Amanda Roloson; Monica Ilies; Charles Perkins; William O'Brien; Stephen Cederbaum; David W Christianson; Nives Zimmermann; Marc E Rothenberg; Fred D Finkelman
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

7.  TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis.

Authors:  Mosiuoa Leeto; De'Broski R Herbert; Reece Marillier; Anita Schwegmann; Lizette Fick; Frank Brombacher
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Fred D Finkelman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 10.  Nitric oxide and respiratory helminthic diseases.

Authors:  Antonio Muro; José-Luís Pérez-Arellano
Journal:  J Biomed Biotechnol       Date:  2010-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.